Immunoregulatory T cells have been identified as key modulators of peripheral tolerance and participate in preventing autoimmune diseases. CD4 À CD8 À (double negative, DN) T cells compose one of these immunoregulatory T-cell subsets, where the injection of DN T cells confers protection from autoimmune diabetes progression. Interestingly, genetic loci defining the function and number of CD4 þ CD25 þ Foxp3 þ regulatory T cells (Tregs) coincide with at least some autoimmune disease susceptibility loci. Herein, we investigate the impact of major insulin-dependent diabetes (Idd) loci in defining the number of DN T cells. We demonstrate that although Idd3, Idd5 and Idd9 loci do not regulate DN T-cell number, NOD mice congenic for diabetes resistance alleles at the Idd13 locus show a partial restoration in DN T-cell number. Moreover, competitive and non-competitive bone marrow chimera experiments reveal that DN T-cell number is defined by a bone marrow-intrinsic, but DN T-cell-extrinsic, factor. This suggests that non-autonomous candidate genes define DN T-cell number in secondary lymphoid organs. Together, our results show that the regulation of DN T-cell number in NOD mice is at least partially conferred by alleles at the Idd13 locus.
INTRODUCTION
As for other common autoimmune diseases, susceptibility to type 1 diabetes is a complex genetic trait.
1,2 NOD mice, which spontaneously develop autoimmune diabetes, have facilitated the study of genetic factors underlying autoimmune diabetes predisposition. 3, 4 To date, more than 20 insulin-dependent diabetes (Idd) loci linked to diabetes susceptibility have been identified in NOD mice (http://www.T1Dbase.org), and the concordance with human diabetes susceptibility has been demonstrated for some of these loci. 4 NOD Idd congenic mice have revealed that many of these loci contribute to immune regulation mediated, at least in part, by CD4 þ CD25 þ Foxp3 þ Tregs. [5] [6] [7] For instance, in addition to conferring diabetes resistance, the Idd3 locus alters the recruitment and function of Tregs. 8, 9 Moreover, the NOD Ctla4 variant, situated within the Idd5.1 locus, is associated with an altered ability of Tregs to downregulate the T-lymphocyte response likely via an inhibitory effect on Treg maintenance and activity. [10] [11] [12] [13] In addition, Treg suppressive functions are improved in the NOD.Idd9 congenic mice, where the Idd9 locus confers partial resistance to disease. [14] [15] [16] Clearly, the genetic control of Tregs is associated with autoimmune diabetes predisposition.
Recently, deficiencies in several other regulatory T-cell subsets have been identified and associated with autoimmune disease susceptibility, including NKT cells, IL-10-producing Tr1 and CD8 þ suppressor T cells. 6, [17] [18] [19] We and others have also demonstrated that a rare immunoregulatory CD4 À CD8 À (double negative, DN) T-cell population is implicated in autoimmune diabetes resistance, where injection of DN T cells reduces diabetes incidence in both a major histocompatibility complex (MHC) class I-and an MHC class II-restricted TCR transgenic model. 20, 21 Moreover, by inserting the MHC class II-restricted 3A9 TCR transgene on various inbred mouse genetic strains, we demonstrated that DN T-cell proportion is inversely correlated with autoimmune diabetes susceptibility. 21 Notably, DN T cells can also be isolated from nontransgenic mice and from humans, where they have been ascribed immunoregulatory functions in various pathological settings. [22] [23] [24] [25] Also, as for TCR transgenic mice, nontransgenic DN T cells are found in lower number in diabetes-prone NOD mice relative to a diabetes-resistant strain. 21 Importantly, although DN T-cell number is low in autoimmune diabetes-prone mice, the immunoregulatory function of DN T cells remains unaltered, 26 pinpointing a biological relevance for the number, rather than function, of these DN T cells.
As low DN T-cell number is associated with autoimmune diabetes predisposition, analysis of NOD.Idd congenic mice may help reveal genetic factors contributing to the homeostatic control of this rare immunoregulatory T-cell population. To assess this possibility, we herein take advantage of the 3A9 TCR transgenic mouse model, which amplifies strain-related differences in DN T-cell number. 21 We evaluate the proportion of DN T cells between different 3A9 TCR transgenic NOD.H2k Idd congenic mice. A partial rescue of DN T-cell number was observed only in 3A9 TCR transgenic NOD.H2k-Idd13 mice, but not in 3A9 TCR NOD.H2k mice bearing the Idd3, -3/5, -5 or -9 loci. Moreover, we find that the proportion of DN T cells is also increased in nontransgenic NOD.NOR-Idd13 mice. We provide evidence suggesting that B2m, a candidate gene included within the Idd13 locus, does not define the proportion of DN T cells. Rather, using bone marrow chimeras, we demonstrate that a hematopoietic-intrinsic, DN T-cell-extrinsic, factor defines DN T-cell proportion.
RESULTS
The Idd13 locus partially restores DN T-cell proportion We have previously demonstrated that genes outside the MHC locus are responsible for autoimmune diabetes susceptibility in the 3A9 TCR:insHEL model, where female TCR:insHEL B10.Br mice are highly resistant to the disease, whereas the diabetes incidence reaches more than 80% in TCR:insHEL NOD.H2k female mice. 27 This antigen-specific mouse model has also facilitated the study of immunoregulatory DN T cells. Indeed, we have shown that a high proportion of DN T cells is associated with resistance to autoimmunity. 21 This trait is not a result of the ongoing autoimmune response, as 3A9 TCR NOD.H2k single transgenic mice, which do not progress to autoimmune diabetes, also present with a much reduced number of DN T cells relative to the 3A9 TCR B10.Br mice. 21 Therefore, low DN T-cell number is a trait conferred by the NOD genetic background, associated with increased predisposition to autoimmune diabetes. The diabetesresistant 3A9 TCR NOD.H2k mice, which bear all the NOD genetic diabetes susceptibility background except for the MHC locus, can thus be effectively used to define the immunogenetic regulation of this lymphocyte subset in the absence of an ongoing autoimmune response.
To examine the contribution of diabetes-resistance genetic loci on the proportion of DN T cells, NOD-Idd3/5 and NOD-Idd9 congenic mice were bred to 3A9 TCR NOD.H2k mice. Our breeding approach allowed us to segregate the Idd3 and Idd5 congenic loci to create four congenic strains, namely 3A9 TCR transgenic NOD.H2k-Idd3, -Idd5, -Idd3/5 and -Idd9 mice. The spleens from these mice were analyzed for the proportion of DN T cells. Note that the 3A9 TCR transgene is incompatible with NKT cell differentiation, such that DN T cells devoid of NKT cells can be readily quantified by the expression of a CD4 À CD8 À 3A9 TCR þ phenotype (Supplementary Figure 1) . 26 Surprisingly, none of these Idd-resistance loci influenced the proportion of DN T cells (Figure 1a) .
Another locus sufficient in itself to decrease the incidence of diabetes in NOD mice is the NOR-derived Idd13 locus. 28, 29 The NOD alleles of the Idd13 locus confer diabetes susceptibility in a T cell-mediated manner, by enhancing the severity of the beta-cell destruction within the islets. 30 In order to evaluate the contribution of the Idd13 locus toward defining DN T-cell number, we bred NOD.NOR-Idd13 mice, wherein the Idd13 interval is of B6 origin, to 3A9 TCR NOD.H2k animals. 29 The resulting 3A9 TCR NOD.H2k-Idd13 congenic mice presented with a significant increase in the proportion of DN T cells in both the spleen and lymph nodes, as well as a significant increase in the absolute number of DN T cells in the spleen, relative to 3A9 TCR NOD.H2k mice (Figure 1b) .
To validate that the effect of the Idd13 locus on DN T-cell proportion was not an artifact of the 3A9 TCR transgenic model, we opted to investigate the impact of the Idd13 locus on DN T cells from nontransgenic mice. Indeed, in nontransgenic animals, DN T cells can be distinguished from other TCRb T-cell populations as they do not express CD4, CD8 or CD19, and do not stain for aGalCer-loaded CD1d tetramer (Figure 2a) . 21, 23 DN T cells also exhibit a low level of CD5 expression ( Figure 2a) . As for 3A9 TCR transgenic mice, the proportion and absolute number of DN T cells were increased in the spleen of nontransgenic NOD.NORIdd13 mice relative to NOD mice ( Figure 2b ) and this difference was observed in mice ranging from 5 to 10 weeks of age (data not shown). Yet, likely due to the onset of the autoimmune response, no significant difference in DN T-cell proportion was observed in the skin-draining lymph nodes, pancreatic lymph nodes and islets of both NOD and NOD.NOR-Idd13 mice (Supplementary Figure 2) . This result confirms that genetic polymorphisms encoded within the Idd13 locus partially restore the proportion and absolute number of DN T cells in the NOD genetic background in both the 3A9 TCR transgenic and nontransgenic setting.
Beta-2 microglobulin does not define DN T-cell number
The Idd13 locus constitutes multiple potentially causative polymorphisms, which are clustered in at least two subloci, namely Idd13.1 and Idd13.2.
28 Although Idd13 contains multiple apoptosisassociated genes with differential gene regulation in NOD mice, 31, 32 B2m (which encodes for beta-2 microglobulin) has been highlighted as the main candidate gene linked to both diabetes resistance and to the regulation of NKT cell proportion. 28, 33, 34 We thus evaluated the impact of B2m deletion on the proportion of DN T cells by breeding 3A9 TCR NOD.H2k mice with NOD.B2m À / À mice. We observed that DN T cells were not reduced in 3A9 TCR NOD.H2k-B2m À / À mice. Rather, we (Figure 3a) . We suspected that, as the B2m deficiency was generated in CBA x C57 mice, genes closely linked to B2m remain of CBA x C57 origin even upon extensive backcrossing to the NOD background (N10) and, consequently, may influence DN T-cell number. To circumvent this issue, we evaluated DN T-cell proportion and number in 3A9 TCR B10.Br mice lacking B2m expression. Similar to the observations made in 3A9 TCR NOD.H2k.B2m
À / À mice, we demonstrate that the loss of function of B2m does not impair DN T-cell proportion and number in 3A9 TCR B10.Br mice (Figure 3b and Supplementary Figure 3) . Therefore, our results suggest that variations in B2m are not responsible for the lower proportion of DN T cells in the NOD.H2k background. DN T-cell number is regulated by cell-extrinsic factors of hematopoietic origin The Idd13 locus partially restores DN T-cell proportion. To define the parameters that determine DN T-cell proportion, we compare their regulation in both 3A9 TCR B10.Br and 3A9 TCR NOD.H2k mice. We have recently shown that the reduction in 3A9 DN T-cell number on the NOD background is not associated with the defect in thymic selection processes, but rather appears to originate from peripheral regulatory mechanisms. 35 Consequently, we generated bone marrow chimeras to investigate whether the proportion of DN T cells is regulated by cell-intrinsic or -extrinsic factors. Accordingly, 3A9 TCR B10.Br and NOD.H2k bone marrow were mixed at a 1:1 ratio into lethally irradiated nontransgenic F1 (B10.Br x NOD.H2k) hosts (Figure 4a ). In this model, bone marrows from both strains differentiate in the same environment, allowing for a direct assessment of their contribution to the DN T-cell pool. As previously shown using this 3A9 TCR transgenic model, 8 weeks of reconstitution is sufficient to allow T-cell homeostasis. 27 Therefore, the contribution of the 3A9 TCR B10.Br or 3A9 TCR NOD.H2k bone marrow to the 3A9 DN T-cell proportion was evaluated in the lymph nodes 8 weeks following reconstitution (see gating strategy Supplementary Figure 4) . Figure 4b demonstrates that both 3A9 TCR B10.Br and 3A9 TCR NOD.H2k bone marrow contribute equally to the reconstitution of the 3A9 DN T-cell population in nontransgenic F1 hosts in a competitive setting. As such, the lower proportion of DN T cells observed in NOD mice is not attributable to a cell-intrinsic defect. Moreover, similar results are obtained when insHEL transgenic F1 hosts were used as recipients showing that the presence of self-antigen does not influence the proportion of 3A9 DN T cells from either the B10.Br or the NOD.H2k genetic background (Figure 4b) . Importantly, in both the nontransgenic and HEL transgenic F1 host, the proportion of 3A9 DN T cells was not influenced by autoimmune diabetes. Indeed, in the nontransgenic F1 hosts, autoimmunity does not develop because of the absence of the cognate antigen in the pancreas, whereas in insHEL F1 recipients, autoimmune diabetes does not develop because the F1 genetic background contributes to autoimmune diabetes resistance. 27 Together, these data suggest that DN T-cell-extrinsic factors define the proportion of DN T cells.
Cell-extrinsic factors influencing the proportion of DN T cells may be of either hematopoietic or non-hematopoietic origin. Accordingly, we performed additional non-competitive bone marrow chimeras to address which component modulates the proportion of DN T cells. Here, nontransgenic or insHEL transgenic F1 recipients were lethally irradiated and reconstituted with 3A9 TCR transgenic bone marrow of either B10.Br or NOD. 
DISCUSSION

DN T cells exhibit a unique antigen-specific immunoregulatory
potential, which has been demonstrated in various experimental settings, including autoimmune diabetes. [20] [21] [22] [23] 36 In our previous work, we have shown that autoimmune-prone mice present with a lower proportion and absolute number of DN T cells in secondary lymphoid organs and that a single injection of DN T cells in diabetes-prone mice was sufficient to prevent diabetes onset. 21, 35 In addition, the immunoregulatory potential of DN T cells in autoimmune-prone mice is comparable to that of DN T cells from diabetes-resistant mice, 26 emphasizing a contribution of the number, and not function, of DN T cells in maintaining immune tolerance. Therefore, identifying the genetic determinants defining the number of DN T cells may unravel key molecular targets to increase DN T-cell number, thereby potentiating antigen-specific immune tolerance.
In the NOD mouse, the onset of the autoimmune response precedes weaning. 37 It is thus difficult to determine whether the phenotypes observed in the NOD strain are a cause or a consequence of the underlying inflammatory response. In addition, by the immunoregulatory nature of DN T cells, one could expect that the proportion or function of DN T cells wanes with the onset of the autoimmune response. To circumvent these issues in exploring the homeostatic regulation of DN T cells, we chose to exploit the 3A9 TCR NOD.H2k model. Indeed, these mice carry the NOD genetic background, except for the MHC locus, allowing us to determine the impact of the NOD genetic background on immune homeostasis in the absence of an underlying autoimmune response. 27 Using this model, we now demonstrate that the Idd13 diabetes resistance alleles from NOD.NOR-Idd13 congenic mice partially restore the proportion of regulatory DN T cells in both 3A9 TCR NOD.H2k transgenic as well as NOD nontransgenic mice. Moreover, we find that the proportion of DN T cells is regulated by a bone marrow-intrinsic DN T-cell-extrinsic factor, guiding the selection of candidate genes important in the regulation of DN T-cell number.
A prized candidate gene for diabetes susceptibility within the Idd13 interval is B2m. 28, 33 B2m encodes for beta-2-microglobulin, a protein necessary for the expression of both MHC class I and class I-like molecules, which include Qa-1 and CD1d. Of interest, rare immunoregulatory T-cell subsets, namely CD8aa T cells and NKT cells, are, respectively, selected on these non-classical MHC class I molecules and are consequently dependent on B2m for their differentiation and survival. 38, 39 To determine whether DN T cells were also dependent on MHC class I or class I-like molecules, we evaluated the impact of B2m deletion on the proportion of DN T cells. However, DN T cells are not reduced in both 3A9 TCR B10.Br and 3A9 TCR NOD.H2k mice deficient for b2m. Rather, in the 3A9 TCR NOD.H2k-B2m
À / À strains, we observed a slight increase in the proportion of DN T cells. Although this could be due to carry over genes from the CBA x C57 background in which the B2m gene was originally deleted, the slight and nonsignificant increase in DN T cells in B2m À / À mice is most likely due to the absence of CD8 þ T lymphocytes. In line with the observation that DN T-cell number is not defined by B2m within the Idd13 locus, the protective B2m allele contributes to diabetes resistance through its expression in the non-hematopoietic compartment, 33 whereas we show that the proportion of DN T cells is defined by a hematopoietic-intrinsic component. Together, these findings suggest that the genetic polymorphism in the B2m resistance allele is unlikely to define the proportion or absolute number of DN T cells. Interestingly, these findings also suggest that 3A9 TCR DN T cells are not dependent on MHC class I and class I-like molecules, and thus are likely selected by a distinct thymic differentiation pathway than both immunoregulatory CD8aa T cells and NKT cells.
The Idd13 locus encodes for several other candidate genes, some of which are implicated in the thymic selection processes. For instance, previous work on thymic differentiation has highlighted Bim as a potential candidate gene within this interval. 32, 40 This Bcl-2 family member is a key pro-apoptotic mediator of negative selection of thymocytes, 41 and is inefficiently upregulated in NOD mice when compared with diabetesresistant B10.Br or B6 animals. 32, 40 Moreover, the Mertk gene is also encoded within the Idd13 interval and has been suggested to participate in autoimmune pathogenesis through the negative regulation of antigen presentation in the thymus. 42 However, we have recently shown that thymic selection processes do not dictate the proportion or the absolute number of DN T cells in secondary lymphoid organs. 35 Indeed, 3A9 DN T cell number is lower in 3A9 TCR NOD.H2k relative to 3A9 TCR B10.Br mice in the absence of the cognate antigen, thus in conditions where negative selection of thymocytes is unlikely to contribute to the difference in DN T-cell proportion between the two mouse strains. These results suggest that peripheral factors are responsible for the reduced proportion of DN T cells in secondary lymphoid Idd13 and DN T-cell number in NOD mice V Dugas et al organs of NOD mice. Still, we cannot yet fully exclude a potential contribution of Bim and Mertk in defining the proportion of DN T cells in secondary lymphoid organs. This will need to be further assessed experimentally.
In addition to DN T cells, the proportion of NKT cells is also regulated by the Idd13 locus 34, 43, 44 and injection of thymic NKT cells in NOD mice protects from autoimmune diabetes. 17 As mentioned above, genetic polymorphisms in B2m define the proportion of NKT cells in NOD mice, suggesting that differentiation of DN T cells and NKT cells are regulated by distinct factors. 33 However, Cd93 was recently proposed as an additional candidate genes within the Idd13 locus contributing toward defining the proportion of NKT cells, at least in the liver. 43 As Cd93 is expressed by some hematopoietic cells, but not T cells, it represents a likely candidate gene defining the number of DN T cells. Interestingly, CD93-deficient mice exhibit a defect in the clearance of apoptotic cells in vivo. 45 We have recently shown that the number of merocytic dendritic cells (mcDCs), which contribute to the clearance of apoptotic cells, 46, 47 is greatly increased in NOD mice in comparison to B6 mice, where the Idd13 B6 alleles decrease the number of mcDC. 48 Hence, it is tempting to suggest that Cd93 regulates mcDC number, which may consequently affect the proportion of both NKT and DN T cells, at least in peripheral tissues, together contributing to autoimmune diabetes susceptibility. Additional studies are needed to determine whether the proportion of mcDC, NKT cells and DN T cells are regulated by the same genetic element within the Idd13 locus.
Similar to Cd93, Sirpa, which encodes for CD172a, is yet another candidate gene included within the Idd13 locus that exhibits a high degree of polymorphism among various inbred mouse strains, including the NOD mouse. 49 In addition, CD172a is also expressed on some hematopoietic cells, but not T cells, 50 which, based on the results from the bone marrow chimera experiments, correspond to the selection criteria of candidate genes defining DN T-cell proportion. Moreover, we demonstrated that mice deficient in CD47, the receptor for CD172a, exhibit a low number of DN T cells and show an enhanced susceptibility to autoimmune diabetes. 21 Finally, the genetic cluster containing the human ortholog of CD172a has recently been associated to autoimmune diabetes. 51 Taken together, these results suggest that Sirpa (CD172a) is also a likely candidate within the Idd13 locus that mediates differential regulation of DN T-cell number and thereby contributes to autoimmune susceptibility.
We have now shown that the diabetes resistance alleles at the Idd13 locus partially restore DN T-cell number in both TCR transgenic and nontransgenic NOD mice. This suggests that the regulation of DN T-cell number is likely to be multigenic. Moreover, we find that the Idd3, Idd5 and Idd9 resistance loci are not involved in defining DN T-cell number, suggesting that, although injection of DN T cells is sufficient to prevent diabetes progression, elevated numbers of DN T cells are not necessary to prevent diabetes progression. As such, we propose that DN T cells compose one of many pathways that participate in maintaining immune tolerance and preventing autoimmunity.
In conclusion, at least five traits are linked to Idd13, namely, the degree of insulitis, thymic selection as well as the number of mcDC, NKT and DN T cells. It is unclear how or whether these traits cooperate in autoimmune diabetes susceptibility. From the description of the two Idd13 congenic sublines, it is likely that at least two genes within the Idd13 locus contribute to diabetes susceptibility. Moreover, using bone marrow chimeras, it was shown that at least part of the resistance is conferred by a factor of non-hematopoietic origin, whereas DN T-cell proportion is defined by at least one hematopoietic factor. NOD.NOR-Idd13 congenic sublines will be needed to further reduce the list of candidate genes within this locus and determine how each of these respective traits contributes to autoimmune diabetes susceptibility.
MATERIALS AND METHODS Mice
3A9 TCR and insHEL (ILK-3) transgenic mice on B10.Br and NOD.H2k background have been previously described. NOD mice congenic for Idd3/5, Idd9 (Taconic line 6109 and 905, gift from LS Wicker) were mated to 3A9 TCR NOD.H2k mice. These Idd congenic mice were maintained at the Mouse Genome Center, Australia, and genotyped for D3nds36 (Idd3), D1Mit74 and D1Mit132 (Idd5), D4Mit76 and D4Mit180 (Idd9). The genetic boundaries can be found on the Taconic website (http://www.taconic.com/). Experiments involving 3A9 TCR NOD.H2k-Idd congenic mice and their appropriate controls were performed at the Mouse Genome Center, Australia. B10.Br, NOD (purchased from Jackson Labs, Bar Harbor, ME, USA) and NOD.NORIdd13 (gift from DV Serreze) nontransgenic mice were maintained at the Maisonneuve-Rosemont Hospital. NOD.B2m À / À (gift from DC Roy, originally from Jackson Labs) and B6.B2m
À / À mice (purchased from Jackson Labs) were mated to 3A9 TCR NOD.H2k and B10.Br animals, respectively. For chimeras, recipient mice were irradiated with 11 Gy and reconstituted with 2 Â 10 6 bone marrow cells. Mice were analyzed 8 weeks post reconstitution. The Maisonneuve-Rosemont Hospital ethics committee overseen by the Canadian Council for Animal Protection approved all experimental procedures.
Flow cytometry
Six-to twelve-week-old non-diabetic mice (Diastix negative) were analyzed. All lymphoid organs were passed through a sterile 70-mm cell strainer. Anti-clonotypic 1G12 antibody 52 was used as a culture supernatant and detected using APC-labeled X56 from BD Biosciences (Mississauga, ON, Canada). All other antibodies were purchased from Biolegend (San Diego, CA, USA). aGalCer-loaded CD1d tetramer is a generous gift from Dr DV Serreze. PBS-57-loaded CD1d tetramer was obtained from the NIH tetramer core facility. Data were collected on a FACSCalibur (BD Biosciences) and analyzed with CellQuest Pro (BD Biosciences) or FlowJo software (Treestar, Ashland, OR, USA).
